A comparative survey study on current prescribing trends in non-steroidal anti-inflammatory drugs among practitioners in private set up and tertiary care teaching rural hospital

Ravi Alamchandani, B. M. Sattigeri, P. S. Karelia


Background: The study was conducted to compare the current prescribing trends of Non-Steroidal Anti-inflammatory drugs (NSAIDS) among private practitioners and practitioners at tertiary care teaching rural hospital.

Methods: The prospective survey study was carried out by obtaining response to feedback questionnaire related to use of NSAIDs from 25 private & 25 tertiary care practitioners.

Results: NSAIDs use was routine amongst private (66%) and tertiary care (77.6%) practitioners. Preferences of tertiary care practitioners were paracetamol (36%), diclofenac (20%), aceclofenac (20%), ibuprofen (20%) and etoricoxib (4%) while that of private practitioners were ibuprofen (40%), paracetamol (32%), diclofenac (16%) and aceclofenac (12%). Use of Fixed Dose Combinations (FDC) was 72% in private and 68% in tertiary care practitioners. While prescribing FDCs, private practitioners preferred NSAIDs + NSAIDs (100%) over NSAIDs + muscle relaxants (44.44%), NSAIDs + Serratiopeptidase (55.56%), and NSAIDs + antacids (44.44%) similarly tertiary care practitioners also preferred NSAIDs + NSAIDs (100%) over NSAIDs + muscle relaxants (47.06%), NSAIDs + Serratiopeptidase (36%), and NSAIDs + antacids (28%). Of the NSAIDs + NSAIDs combination ibuprofen + paracetamol (70%) was preferred by private practitioners and diclofenac + paracetamol (61%) by tertiary practitioners. Paracetamol was safely used during pregnancy by both groups. Adverse effects observed included gastritis (98%), urticaria (32%), and anaphylaxis (2%), although no fatality was observed.

Conclusion: Not much of a difference was observed in prescribing habits of both groups. Though beneficial and routinely prescribed, NSAIDs with equal risk potential were observed to be cautiously used with appropriate knowledge amongst both the groups.



Fixed dose combinations, NSAIDs, Private practitioner, Tertiary care practitioners

Full Text:



Chambers HF. General Principles of antimicrobial therapy. In: Brunton LL, editor. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2010. p. 1095-110.

Keys J et al. General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions. Journal of the Royal Society of Medicine 1992 Aug;85:442-445.

Tripathi KD. Nonsteroidal Antiinflammatory Drugs and Antipyretic-Analgesics. In, Tripathi KD (ed), Essentials of Medical Pharmacology, 6th Edition. New Delhi, Jaypee Brothers Medical Publishers, 2009; 184-201.

Laine L. The gastrointestinal effects of non-selective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 2002;32:25-32.

Whelton A. Renal aspects of treatment with conventional non-steroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med 2001;110:33S-42S.

Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:c7086.

Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-8.

Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth. 2002 Feb;88(2): 199-214.

Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol. 2005 Nov;32(11):2218-24.

Dreillard, Audrey. "Grossesse - Mamans attention" (in French). France Soir 2009 Mar 02. Available at http://www.francesoir.fr/societe/2009/03/02/grossesse-mamans-attention.html. Accessed 27 November 2013.

Leffers; et al (2010). "Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat". Human Reproduction. 25 (1): 235-44.

Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001 Feb 3;322(7281): 266-70.

Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368.

Otto A. NSAID Use During Pregnancy Linked to Pulmonary Hypertension In Newborns. Pharmacy Today.2001;7(5).

Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology: Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728-38.